PMC:7558233 / 32008-32251
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"756","span":{"begin":221,"end":226},"obj":"Gene"},{"id":"785","span":{"begin":29,"end":40},"obj":"Chemical"},{"id":"786","span":{"begin":196,"end":215},"obj":"Chemical"}],"attributes":[{"id":"A756","pred":"tao:has_database_id","subj":"756","obj":"Gene:3439"},{"id":"A785","pred":"tao:has_database_id","subj":"785","obj":"MESH:C462182"},{"id":"A786","pred":"tao:has_database_id","subj":"786","obj":"MESH:C558899"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In a pilot open-label study, favipiravir was shown to markedly shorten the time to viral clearance and increase the rate of improvement in chest imaging compared with a combination treatment with lopinavir/ritonavir plus IFN-α inhalation [89]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T192","span":{"begin":0,"end":243},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In a pilot open-label study, favipiravir was shown to markedly shorten the time to viral clearance and increase the rate of improvement in chest imaging compared with a combination treatment with lopinavir/ritonavir plus IFN-α inhalation [89]."}